Standards for PET Image Acquisition and Quantitative Data Analysis
暂无分享,去创建一个
[1] Clifford Goodman,et al. Society of Nuclear Medicine , 1988 .
[2] U Ruotsalainen,et al. Influence of the blood glucose concentration on FDG uptake in cancer--a PET study. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] J. Keyes. SUV: standard uptake or silly useless value? , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] J M Hoffman,et al. Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] L M Hamberg,et al. Simplified measurement of deoxyglucose utilization rate. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] N. Gupta,et al. Dependency of standardized uptake values of fluorine-18 fluorodeoxyglucose on body size: comparison of body surface area correction and lean body mass correction. , 1996, Nuclear medicine communications.
[7] D. Mankoff,et al. Tumor metabolic rates in sarcoma using FDG PET. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] Norihiro Sadato,et al. Non-invasive estimation of the net influx constant using the standardized uptake value for quantification of FDG uptake of tumours , 1998, European Journal of Nuclear Medicine.
[9] R L Wahl,et al. Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] K. Herholz,et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. , 1999, European journal of cancer.
[11] A. Lammertsma,et al. Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods , 2000, European Journal of Nuclear Medicine.
[12] M. Graham,et al. Comparison of simplified quantitative analyses of FDG uptake. , 2000, Nuclear medicine and biology.
[13] D. Visvikis,et al. Influence of OSEM and segmented attenuation correction in the calculation of standardised uptake values for [18F]FDG PET , 2001, European Journal of Nuclear Medicine.
[14] J. Vansteenkiste,et al. The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology. , 2001, The European respiratory journal.
[15] Johan Nuyts,et al. Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] Lilli Geworski,et al. Multicenter comparison of calibration and cross calibration of PET scanners. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] Mark Muzi,et al. Quantitative positron emission tomography imaging to measure tumor response to therapy: what is the best method? , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[18] Paul E Kinahan,et al. Evaluating image reconstruction methods for tumor detection in 3-dimensional whole-body PET oncology imaging. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] B. Chauffert,et al. Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002) , 2003, British Journal of Cancer.
[20] Cyrill Burger,et al. Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] R. Wahl,et al. Initial experience with oral contrast in PET/CT: phantom and clinical studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] Adriaan A. Lammertsma,et al. Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[23] R. Boellaard,et al. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] W Vaalburg,et al. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. , 2004, Cancer treatment reviews.
[25] Thomas Beyer,et al. Acquisition protocol considerations for combined PET/CT imaging. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] J. Thie. Understanding the standardized uptake value, its methods, and implications for usage. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] M. Schwaiger,et al. Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[28] A. Pevsner,et al. The CT motion quantitation of lung lesions and its impact on PET-measured SUVs. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[29] Jason P Fine,et al. Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] R. Coleman,et al. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[31] T. Beyer,et al. Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] S. Raman,et al. Whole-body PET/CT: Spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients , 2005, Nuclear medicine communications.
[33] Wolfgang A Weber,et al. Use of PET for monitoring cancer therapy and for predicting outcome. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[34] Otto S Hoekstra,et al. Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] Wolfgang A Weber,et al. Monitoring response to treatment in patients utilizing PET. , 2005, Radiologic clinics of North America.
[36] W. Weber,et al. PET for response assessment in oncology: radiotherapy and chemotherapy , 2005 .
[37] Joos V Lebesque,et al. Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. , 2005, European journal of cancer.
[38] Eric J. W. Visser,et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[39] Anne Bol,et al. A gradient-based method for segmenting FDG-PET images: methodology and validation , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[40] Adriaan A. Lammertsma,et al. How should we analyse FDG PET studies for monitoring tumour response? , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[41] Ursula Nestle,et al. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[42] Marc Kachelriess,et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[43] Tinsu Pan,et al. Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation. , 2006, AJR. American journal of roentgenology.
[44] Joel Karp,et al. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[45] Lawrence H Schwartz,et al. 18F-FDG PET as a candidate for "qualified biomarker": functional assessment of treatment response in oncology. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[46] W. Weber. Chaperoning drug development with PET. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[47] D. Mankoff,et al. Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] Sigrid Stroobants,et al. Revised response criteria for malignant lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] The role of FDG PET in the management of lymphoma: practical guidelines. , 2007, Nuclear medicine communications.
[50] James H Thrall,et al. FDG-PET CT for tumor imaging. , 2007, Journal of the American College of Radiology : JACR.
[51] D Visvikis,et al. Fuzzy hidden Markov chains segmentation for volume determination and quantitation in PET. , 2007, Physics in medicine and biology.
[52] I. Buvat,et al. Partial-Volume Effect in PET Tumor Imaging* , 2007, Journal of Nuclear Medicine.
[53] PET/CT in cancer patient management. Introduction. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[54] PL2-03: New imaging techniques (PET, PET/CT, MRI, E(B)US.) for lung cancer staging and response assessment , 2007 .
[55] Mark Muzi,et al. Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond , 2007, Clinical Cancer Research.
[56] Klemens Scheidhauer,et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[57] Integrated PET/CT in lung cancer imaging: history and technical aspects. , 2007, JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie.
[58] Yusuf Emre Erdi,et al. The Use of PET for Radiotherapy , 2007 .
[59] W. Oyen,et al. Predictive and prognostic value of FDG‐PET in nonsmall‐cell lung cancer , 2007, Cancer.
[60] K. Murase,et al. Variability of lesion detectability and standardized uptake value according to the acquisition procedure and reconstruction among five PET scanners , 2008, Annals of nuclear medicine.
[61] R. Coleman,et al. Recommendations on the Use of 18F-FDG PET in Oncology , 2008, Journal of Nuclear Medicine.
[62] G Bosmans,et al. Respiratory-gated CT as a tool for the simulation of breathing artifacts in PET and PET/CT. , 2006, Medical physics.
[64] A. Alavi,et al. Quantitative Assessment of FDG Uptake in Brown Fat Using Standardized Uptake Value and Dual-Time-Point Scanning , 2008, Clinical nuclear medicine.
[65] Ronald Boellaard,et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[66] Julie R. Gralow,et al. Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[67] Andre Dekker,et al. The integration of PET-CT scans from different hospitals into radiotherapy treatment planning. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[68] W. Oyen,et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[69] L. Schwartz,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.